skip to Main Content

Image montage of TAG Limited Art Editions
image that reads Research in Action Awards, November 16, 2021. Red background with white type and TAG in a black circle
Image link to About the COVID-19 Project page
Pipeline Report 2021 Cover

Pipeline Reports

The current ones are all online and available for download now.

 

 

January 26, 2022
2022 Pre- and Post-CROI Community HIV Cure Research Workshop
Webinar / Presentation
The 2022 Community HIV Cure Research Workshop will again take place virtually this year due to the ongoing COVID-19 pandemic. There will be two sessions, the first on Tuesday February 8th and the second on Tuesday March 1st.

January 14, 2022
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).

January 12, 2022
Integration of Viral Hepatitis Prevention and Treatment for People Who Inject Drugs
On February 3, 2022, TAG in collaboration with the International Network of People who Use Drugs (INPUD), Harm Reduction International (HRI), and the World Hepatitis Alliance (WHA), will host this free webinar.

January 11, 2022
Grant Officer
TAG is seeking a dynamic, highly motivated, and organized Grant Officer to support grant and fundraising efforts. This position will report to TAG’s Director of Development, and is a full-time, salaried role. Apply today!

December 22, 2021
Statement from TAG’s HIV Project on FDA’s Approval of Injectable Pre-Exposure Prophylaxis
Statement / Press
Treatment Action Group (TAG) welcomes and celebrates the U.S. Food and Drug Administration’s (FDA) approval of Apretude brand cabotegravir, the first injectable medication for use as pre-exposure prophylaxis (PrEP) to reduce the risk of HIV transmission.

Back To Top